Documents/HHSFACA109

FACA Committee Purpose & Justification

Strategic_Plan

Start: 2010-10-01, End: 2011-09-30, Publication: 2013-07-09

Source: http://explore.data.gov/resource/datasets/c5i3-bb9j

The information in this plan was imported from the Federal Advisory Committee Act (FACA) database and transformed into StratML Part 1, Strategic Plan, format.

Fiscal Year:2011 Committee Type: Scientific Technical Program Advisory Board

Submitter:

Name:Gannon (J.) Dick

Email:gannon_dick@yahoo.com

Organization:

Name:Anti Infective Drugs Advisory Committee

Acronym:HHS

Description:
[109]: http://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/Anti-InfectiveDrugsAdvisoryCommittee/default.htm

Stakeholder(s):

  • Department of Health and Human Services: [32]: http://www.hhs.gov/
    • Sponsoring Agency (Beneficiary)

  • Wallace Kemper Alston: Professor of Medicine Div of Infectious Medicine University of Vermont
    • Committee Member (Performer): Special Government Employee (SGE)

  • Paul G. Auwaerter M.D.: Clinical Director, Johns Hopkins University School of Medicine
    • Committee Member (Performer): Special Government Employee (SGE)

  • Diane M. Cappelletty Pharm.D.: Associate Professor of Pharmacy Practice, University of Toledo
    • Committee Member (Performer): Special Government Employee (SGE)

  • Archana no middle name Chatterjee: Chief Pediatric Infectious Disease Creighton University Medical Center
    • Committee Member (Performer): Special Government Employee (SGE)

  • Dean A. Follmann: Assistant Director for Biostatistics National Institute of Allergy and Infectious Diseases
    • Committee Member (Performer): Regular Government Employee (RGE)

  • Matthew Bidwell Goetz: Chief, Infectious Disease VA Greater Los Angeles Healthcare System
    • Committee Member (Performer): Regular Government Employee (RGE)

  • Sheldon Lee Kaplan: Chief, Infectious Disease Service, Texas Children's Hospital
    • Committee Member (Performer): Special Government Employee (SGE)

  • Peter no middle name Katona: Associate Professor of Clinical Medicine The David Geffen School of Medicine at UCLA
    • Committee Member (Performer): Special Government Employee (SGE)

  • Thomas Allen Moore M.D., FACP: Chairman, Department of Infectious Diseases, Ochsner Health System
    • Committee Member (Performer): Special Government Employee (SGE)

  • Michael N. Neely M.D.: Assistant Professor of Clinical Pediatrics
    • Committee Member (Performer): Special Government Employee (SGE)

  • Susan Joellen Rehm: Assistant Clinical Professor Dept. of Infectious Disease Cleveland Clinic Foundation
    • Committee Member (Performer): Special Government Employee (SGE)

  • Dr. John H. Rex M.D., FACP: Industry Representative, AstraZeneca
    • Committee Member (Performer): Representative

  • Kent Arthur Sepkowitz: Vice Chair Dept. Medicine Memorial Sloan-Kettering Cancer Center
    • Committee Member (Performer): Special Government Employee (SGE)

  • Melvin Phillip Weinstein: Professor of Medicine and Pathology, UMDNJ Robert Wood Johnson Medical School
    • Committee Member (Performer): Special Government Employee (SGE)

  • Kathleen T. Young: Director, Alliance for Prudent Use of Atibiolotics
    • Committee Member (Performer): Special Government Employee (SGE)